Literature DB >> 25739415

Developments in intracerebral stem cell grafts.

Stephanny Reyes1, Naoki Tajiri, Cesar V Borlongan.   

Abstract

The field of stem cell therapy has emerged as a promising research area for brain repair. Optimizing the safety and efficacy of the therapy for clinical trials will require revisiting transplantation protocols. The cell delivery route stands as a key translational item that warrants careful consideration in facilitating the success of stem cell therapy in the clinic. Intracerebral administration, compared to peripheral route, requires an invasive procedure to directly implant stem cells into injured brain. Although invasive, intracerebral transplantation circumvents the prohibitive blood brain barrier in allowing grafted cells when delivered peripherally to penetrate the brain and reach the discreet damaged brain tissues. This review will highlight milestone discoveries in cell therapy for neurological disorders, with emphasis on intracerebral transplantation in relevant animal models and provide insights necessary to optimize the safety and efficacy of cell therapy for the treatment of Parkinson's disease, Huntington's disease, stroke and traumatic brain injury.

Entities:  

Keywords:  cell delivery; neurodegeneration; neurological disorders; stem cell therapy; translational research

Mesh:

Year:  2015        PMID: 25739415      PMCID: PMC4681443          DOI: 10.1586/14737175.2015.1021787

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN: 1473-7175            Impact factor:   4.618


  66 in total

1.  Transplantation of fetal kidney tissue reduces cerebral infarction induced by middle cerebral artery ligation.

Authors:  Y H Chiang; S Z Lin; C V Borlongan; B J Hoffer; M Morales; Y Wang
Journal:  J Cereb Blood Flow Metab       Date:  1999-12       Impact factor: 6.200

2.  Human Wharton's Jelly-Derived Stem Cells Display Immunomodulatory Properties and Transiently Improve Rat Experimental Autoimmune Encephalomyelitis.

Authors:  Raf Donders; Marjan Vanheusden; Jeroen F J Bogie; Stylianos Ravanidis; Kristof Thewissen; Piet Stinissen; Wilfried Gyselaers; Jerome J A Hendriks; Niels Hellings
Journal:  Cell Transplant       Date:  2014-10-10       Impact factor: 4.064

Review 3.  Stem cell technology for neurodegenerative diseases.

Authors:  J Simon Lunn; Stacey A Sakowski; Junguk Hur; Eva L Feldman
Journal:  Ann Neurol       Date:  2011-09       Impact factor: 10.422

4.  Lumbar intraspinal injection of neural stem cells in patients with amyotrophic lateral sclerosis: results of a phase I trial in 12 patients.

Authors:  Jonathan D Glass; Nicholas M Boulis; Karl Johe; Seward B Rutkove; Thais Federici; Meraida Polak; Crystal Kelly; Eva L Feldman
Journal:  Stem Cells       Date:  2012-06       Impact factor: 6.277

Review 5.  The battle of the sexes for stroke therapy: female- versus male-derived stem cells.

Authors:  Yuji Kaneko; Travis Dailey; Nathan L Weinbren; Jessica Rizzi; Cyrus Tamboli; Julie G Allickson; Nicole Kuzmin-Nichols; Paul R Sanberg; David J Eve; Naoki Tajiri; Cesar V Borlongan
Journal:  CNS Neurol Disord Drug Targets       Date:  2013-05-01       Impact factor: 4.388

6.  Dopaminergic microtransplants into the substantia nigra of neonatal rats with bilateral 6-OHDA lesions. I. Evidence for anatomical reconstruction of the nigrostriatal pathway.

Authors:  G Nikkhah; M G Cunningham; M A Cenci; R D McKay; A Björklund
Journal:  J Neurosci       Date:  1995-05       Impact factor: 6.167

7.  Risk factors in the development of stem cell therapy.

Authors:  Carla A Herberts; Marcel S G Kwa; Harm P H Hermsen
Journal:  J Transl Med       Date:  2011-03-22       Impact factor: 5.531

8.  Therapeutic effects of human umbilical cord blood-derived mesenchymal stem cells after intrathecal administration by lumbar puncture in a rat model of cerebral ischemia.

Authors:  Jung Yeon Lim; Chang Hyun Jeong; Jin Ae Jun; Seong Muk Kim; Chung Heon Ryu; Yun Hou; Wonil Oh; Jong Wook Chang; Sin-Soo Jeun
Journal:  Stem Cell Res Ther       Date:  2011-09-22       Impact factor: 6.832

9.  Stem cell recruitment of newly formed host cells via a successful seduction? Filling the gap between neurogenic niche and injured brain site.

Authors:  Naoki Tajiri; Yuji Kaneko; Kazutaka Shinozuka; Hiroto Ishikawa; Ernest Yankee; Michael McGrogan; Casey Case; Cesar V Borlongan
Journal:  PLoS One       Date:  2013-09-04       Impact factor: 3.240

Review 10.  Mesenchymal stem cells migration homing and tracking.

Authors:  Abhishek Sohni; Catherine M Verfaillie
Journal:  Stem Cells Int       Date:  2013-09-30       Impact factor: 5.443

View more
  7 in total

1.  Preliminary Reports of Stereotaxic Stem Cell Transplants in Chronic Stroke Patients.

Authors:  Cesar V Borlongan
Journal:  Mol Ther       Date:  2016-10       Impact factor: 11.454

Review 2.  Treating childhood traumatic brain injury with autologous stem cell therapy.

Authors:  Shyam Dewan; Samantha Schimmel; Cesar V Borlongan
Journal:  Expert Opin Biol Ther       Date:  2018-02-15       Impact factor: 4.388

Review 3.  Growth factor therapy sequesters inflammation in affording neuroprotection in cerebrovascular diseases.

Authors:  Hung Nguyen; David Aum; Sherwin Mashkouri; Gautam Rao; Juan Diego Vega Gonzales-Portillo; Stephanny Reyes; Cesario V Borlongan
Journal:  Expert Rev Neurother       Date:  2016-05-13       Impact factor: 4.618

4.  The future of stem cell therapy for stroke rehabilitation.

Authors:  Cesar V Borlongan; Jukka Jolkkonen; Olivier Detante
Journal:  Future Neurol       Date:  2015-08

Review 5.  Translational considerations in injectable cell-based therapeutics for neurological applications: concepts, progress and challenges.

Authors:  Mahetab H Amer; Felicity R A J Rose; Kevin M Shakesheff; Michel Modo; Lisa J White
Journal:  NPJ Regen Med       Date:  2017-08-10

Review 6.  Neural and mesenchymal stem cells in animal models of Huntington's disease: past experiences and future challenges.

Authors:  Irina Kerkis; Monica Santoro Haddad; Cristiane Wenceslau Valverde; Sabina Glosman
Journal:  Stem Cell Res Ther       Date:  2015-12-14       Impact factor: 6.832

7.  Transplantation of bone marrow mesenchymal stem cells improves cognitive deficits and alleviates neuropathology in animal models of Alzheimer's disease: a meta-analytic review on potential mechanisms.

Authors:  Chuan Qin; Yalan Lu; Kewei Wang; Lin Bai; Guiying Shi; Yiying Huang; Yongning Li
Journal:  Transl Neurodegener       Date:  2020-05-27       Impact factor: 8.014

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.